Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer

被引：22
|
作者：
Boeck, Stefan [1 ]
Heinemann, Volker [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Klinikum Grosshadern, Dept Internal Med 3, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 07期
关键词：
D O I：
10.1200/JCO.2007.15.3304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1178 / 1179
页数：2
相关论文
共 50 条
  • [21] Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer
    Tsang, Erica S.
    Wong, Hui-li
    Wang, Ying
    Renouf, Daniel J.
    Cheung, Winson Y.
    Lim, Howard J.
    Gill, Sharlene
    Loree, Jonathan M.
    Kennecke, Hagen F.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (02): : 196 - 201
  • [22] Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study
    Saif, Muhammad Wasif
    Syrigos, Kostas
    Penney, Robin
    Kaley, Kristin
    [J]. ANTICANCER RESEARCH, 2010, 30 (07) : 2905 - 2909
  • [23] Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer
    Tsang, Erica S.
    Wong, Hui-Li
    Wang, Ying
    Renouf, Daniel John
    Cheung, Winson Y.
    Lim, Howard John
    Gill, Sharlene
    Loree, Jonathan M.
    Kennecke, Hagen F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [24] Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis
    Lino, Aline da Rocha
    Abrahao, Carina Meira
    Brandao, Raphael Moreira
    Gomes, Jessica Ribeiro
    Ferrian, Andrea Malta
    Cesar Machado, Marcel Cerqueira
    Buzaid, Antonio Carlos
    Maluf, Fernando Cotait
    Peixoto, Renata D'Alpino
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (05) : 511 - 515
  • [25] Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
    Girardi, Daniel M.
    Faria, Luiza Dib B. B.
    Teixeira, Marcela C.
    Costa, Frederico P.
    Hoff, Paulo Marcelo G.
    Fernandes, Gustavo S.
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 860 - 866
  • [26] Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
    Daniel M. Girardi
    Luiza Dib B. B. Faria
    Marcela C. Teixeira
    Frederico P. Costa
    Paulo Marcelo G. Hoff
    Gustavo S. Fernandes
    [J]. Journal of Gastrointestinal Cancer, 2019, 50 : 860 - 866
  • [27] Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Tschoep-Lechner, Katharina Elisabeth
    Milani, Valeria
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf-Dieter
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (01) : 8 - 16
  • [28] GEMCITABINE AND CISPLATIN COMBINED WITH REGIONAL HYPERTHERMIA AS SECOND-LINE TREATMENT IN PATIENTS WITH GEMCITABINE-REFRACTORY ADVANCED PANCREATIC CANCER
    Lechner, Katharina
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
  • [29] A Multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer
    Ignatiadis, Michail
    Polyzos, Aris
    Stathopoulos, George P.
    Tselepatiotis, Evangelos
    Christophylakis, Charalambos
    Kalbakis, Kostas
    Vamvakas, Lambros
    Kotsakis, Athanasios
    Potamianou, Anna
    Georgoulias, Vassilis
    [J]. ONCOLOGY, 2006, 71 (3-4) : 159 - 163
  • [30] Overall Survival of Patients with Advanced Pancreatic Cancer Improved with an Increase in Second-Line Chemotherapy after Gemcitabine-Based Therapy
    Zhang, Yuan-Dong
    Yang, Qiong
    Jiang, Zhi-min
    Ma, Wen
    Zhou, Si-wei
    Xie, De-rong
    [J]. JOURNAL OF THE PANCREAS, 2011, 12 (02): : 131 - 137
12345